MarginsXMarginsX
Home › Markets › Health Care › XAIR

Beyond Air Inc. (XAIR)

XAIR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.02
-5.16% on the day
Market cap
$3.4M
Nano cap
Revenue · 2025
$7.7M
+107.3% on 2024
Net income · 2025
-$33.2M
-433.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1641631/000149315226030287/0001493152-26-030287-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.

Profile

FieldValue
TickerXAIR on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001641631
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$7.7M
Net income-$33.2M
Operating income-$29.0M
Net margin-433.0%
Operating margin-378.2%
Revenue growth+107.3%
Cash$6.7M
Total assets$35.4M
P/E (computed)Net income was not positive
P/S (computed)0.4×

Warning signs

Cash runway
3.3 months
$5.4M cash at September 30, 2026
Share count, 1 year
+316.0%
2025-11-07 to 2026-11-10 · +1984.4% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$225K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$5.4M cash; operating cash flow -$4.9M a quarter.Report 2026-09-30
Shares outstanding1,666,104 (2026-11-10); 8,009,488 a year earlier; 31,972,434 three years earlier. 1y figure adjusted for splits (1-for-20 overall); 3y figure adjusted for splits (1-for-400 overall).Cover page 2026-11-10
Reverse splits, 3 years2; latest 1-for-20 on 2026-07-13Source 2026-07-13
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-08-17
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-10
AuditorWithumSmith+Brown, PC, East Brunswick, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2024-12-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $225K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2027
2026-09-30
$2.3M-$7.8M-$5.6M$5.4M$58K$8.2M10-Q 2026-11-12
Q1 2027
2026-06-30
$1.8M-$7.9M-$4.9M$5.5M$231K$7.7M10-Q 2026-08-13
Q4 2026
2026-03-31
$1.9M-$10.3M-$4.9M$6.7M$802K$7.7M10-K 2026-06-26
Q3 2026
2025-12-31
$2.2M-$7.3M-$4.2M$6.6MNo debt tags$6.9M10-Q 2026-02-13
Q2 2026
2025-09-30
$1.8M-$7.9M-$4.5M$9.7MNo debt tags$5.8M10-Q 2026-11-12
Q1 2026
2025-06-30
$1.8M-$7.7M-$4.5M$5.0M$233K$4.8M10-Q 2026-08-13
Q4 2025
2025-03-31
$1.2M-$8.0M-$7.0M$4.7M$1.2M$3.7M10-K 2026-06-26
Q3 2025
2024-12-31
$1.1M-$13.0M-$7.7M$4.6M$11.8M$3.0M10-Q 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-08-24
Latest annual report10-K2026-06-26
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-13
Latest proxyDEFA14A2026-10-30

Source: SEC EDGAR submissions feed, 635 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.4%
1 month-2.7%
3 months-69.2%
Year to date-85.3%
1 year-92.6%
From 52-week high-95.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
TNONTenon Medical Inc.$1.33-5.32%$3.6M
VVOSVivos Therapeutics Inc.$0.0822-16.12%$2.8M
IVFINVO Fertility Inc.$2.40-7.69%$2.8M
NVNOenVVeno Medical Corporation$5.95-3.65%$4.1M
ICCMIceCure Medical Ltd.$0.7601+4.12%$2.6M
BJDXBluejay Diagnostics Inc.$2.29-12.26%$2.6M
SNOASonoma Pharmaceuticals Inc.$0.8802-19.25%$4.5M
BDMDBaird Medical Investment Holdings Ltd Ordinary Share$0.1065+17.68%$4.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier